 Nymox Pharmaceutical Corporation NYMX is pleased to provide an up-to-date investor communication presentation posted on the Nymox website today as the end of second quarter update for shareholders. The new company presentation is on the Nymox website under Investors, and Company Presentation. In addition, the Company management will be available for further discussion and clarifications by contacting Erik Danielsen, Nymox CFO at or by telephone at 800-936-9669 the new presentation and telephone follow-up will replace the teleconference for this quarter. 